CinCor Pharma, Inc.
News
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
Globe Newswire Trudhesa Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022 Trudhesa Net Product Revenue in Q1 2023 Increased 149% vs. Q1 2022 to $4.4 Million Impel to Host Investor Conference Call Today at 8:30 a.m. ET SEATTLE, May 12, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ: ...\n more…
Tudor Investment Corp Et Al Makes New Investment in CinCor Pharma, Inc. (NASDAQ:CINC)
Ticker Report Tudor Investment Corp Et Al bought a new position in shares of CinCor Pharma, Inc. (NASDAQ:CINC Get Rating) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities Exchange Commission. The institutional investor bought 21,805 shares of the ...\n more…
CinCor Pharma, Inc. (NASDAQ:CINC) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Zolmax Shares of CinCor Pharma, Inc. (NASDAQ:CINC Get Rating) have been given a consensus rating of Hold by the six brokerages that are presently covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. ...\n more…
CinCor Pharma, Inc. (NASDAQ:CINC) Receives $49.00 Average PT from Brokerages
Ticker Report CinCor Pharma, Inc. (NASDAQ:CINC Get Rating) has received an average recommendation of Hold from the six brokerages that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and two have issued a buy ...\n more…
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
Globe Newswire WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (CinCor or the Company) announced today completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) on the anticipated Phase 3 program for baxdrostat in hypertension. Baxdrostat is a once daily ...\n more…